"breast cancer survival" trang 6 - tải miễn phí từ tailieunhanh
Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): Design of a clinical trial

Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): Design of a clinical trial
13    76    1
Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: Exploratory study using primary and paired metastatic lesions

Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: Exploratory study using primary and paired metastatic lesions
14    77    1
SAKK 24/09: Safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2- negative advanced stage breast cancer - a multicenter, randomized phase III trial

SAKK 24/09: Safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2- negative advanced stage breast cancer - a multicenter, randomized phase III trial
8    54    1
Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia

Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia
12    59    1
Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: Results of the CECOG LaVie trial

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: Results of the CECOG LaVie trial
7    73    1
Prognostic value of ERBB4 expression in patients with triple negative breast cancer

Prognostic value of ERBB4 expression in patients with triple negative breast cancer
12    51    1
Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival

Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival
14    31    1
Long-term survival and BRCA status in male breast cancer: A retrospective single-center analysis

Long-term survival and BRCA status in male breast cancer: A retrospective single-center analysis
11    71    1
Eribulin-induced liver dysfunction as a prognostic indicator of survival of metastatic breast cancer patients: A retrospective study

Eribulin-induced liver dysfunction as a prognostic indicator of survival of metastatic breast cancer patients: A retrospective study
9    45    1
Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: A competing risk analysis

Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: A competing risk analysis
9    48    1
Socioeconomic disparities in breast cancer incidence and survival among parous women: Findings from a population-based cohort, 1964-2008

Socioeconomic disparities in breast cancer incidence and survival among parous women: Findings from a population-based cohort, 1964-2008
11    42    1
Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival

Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival
15    23    1
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients

Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients
9    33    1
Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer

Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer
10    41    1
Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling

Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling
13    20    1
COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer

COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer
10    62    1
Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: First report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial

Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: First report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial
14    31    1
High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients

High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients
11    49    1
IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort

IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort
16    26    1
Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status

Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status
12    37    1